Advertisement

Engineering Antibodies on the Surface of CHO Cells

  • Annalee W. NguyenEmail author
  • Kevin Le
  • Jennifer A. Maynard
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 2070)

Abstract

While antibody libraries are traditionally screened in phage, bacterial, or yeast display formats, they are produced in large scale for pharmaceutical and commercial use in mammalian cell lines. The simpler organisms used for screening have significantly different folding and glycosylation machinery than mammalian cells; consequently, clones resulting from these libraries may require further optimization for mammalian cell expression. To streamline the antibody discovery process, we developed a Chinese hamster ovary (CHO) cell-based selection system that allows for long-term display of antibody Fab fragments. This system is facilitated by a semi-stable Epi-CHO episomal platform to maintain antibody expression for up to 2 months and is compatible with standard PCR-based mutagenesis strategies. This protocol describes the simple and accessible use of CHO display coupled with flow cytometry to enrich for antibody variants with increased ligand-binding affinity from large libraries of ~106 variants, using HER2-binding antibodies as an example.

Key words

Surface display CHO Antibody engineering Mammalian Glycosylation 

Supplementary material

465800_1_En_22_MOESM1_ESM.docx (31 kb)
Supplementary Fig. 1 4D5 and bD1 Fab display coding sequences. The DNA and amino acid (AA) sequences of both 4D5 and bD1 are shown with dashes where sequence is absent and dots for identical DNA or amino acids. Helpful cloning sites are highlighted in grey. Regions of interest are labeled above and underlined with beginning and end of the region indicated by arrows. Three dots (...) indicate identical DNA sequence to 4D5, and one dot (.) indicates identical amino acid sequence to 4D5. Double underline indicates amino acids targeted for mutagenesis (DOCX 31 kb)

References

  1. 1.
    Hoogenboom HR (2005) Selecting and screening recombinant antibody libraries. Nat Biotechnol 23(9):1105–1116.  https://doi.org/10.1038/nbt1126CrossRefGoogle Scholar
  2. 2.
    Nieba L, Honegger A, Krebber C, Pluckthun A (1997) Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment. Protein Eng 10(4):435–444CrossRefGoogle Scholar
  3. 3.
    Ni M, Lee AS (2007) ER chaperones in mammalian development and human diseases. FEBS Lett 581(19):3641–3651.  https://doi.org/10.1016/j.febslet.2007.04.045CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Wildt S, Gerngross TU (2005) The humanization of N-glycosylation pathways in yeast. Nat Rev Microbiol 3(2):119–128.  https://doi.org/10.1038/nrmicro1087CrossRefPubMedGoogle Scholar
  5. 5.
    Bradbury AR, Sidhu S, Dubel S, McCafferty J (2011) Beyond natural antibodies: the power of in vitro display technologies. Nat Biotechnol 29(3):245–254.  https://doi.org/10.1038/nbt.1791CrossRefGoogle Scholar
  6. 6.
    Beerli RR, Bauer M, Buser RB, Gwerder M, Muntwiler S, Maurer P, Saudan P, Bachmann MF (2008) Isolation of human monoclonal antibodies by mammalian cell display. Proc Natl Acad Sci U S A 105(38):14336–14341.  https://doi.org/10.1073/pnas.0805942105CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Bowers PM, Horlick RA, Kehry MR, Neben TY, Tomlinson GL, Altobell L, Zhang X, Macomber JL, Krapf IP, Wu BF, McConnell AD, Chau B, Berkebile AD, Hare E, Verdino P, King DJ (2014) Mammalian cell display for the discovery and optimization of antibody therapeutics. Methods 65(1):44–56.  https://doi.org/10.1016/j.ymeth.2013.06.010CrossRefPubMedGoogle Scholar
  8. 8.
    Bowers PM, Horlick RA, Neben TY, Toobian RM, Tomlinson GL, Dalton JL, Jones HA, Chen A, Altobell L 3rd, Zhang X, Macomber JL, Krapf IP, Wu BF, McConnell A, Chau B, Holland T, Berkebile AD, Neben SS, Boyle WJ, King DJ (2011) Coupling mammalian cell surface display with somatic hypermutation for the discovery and maturation of human antibodies. Proc Natl Acad Sci U S A 108(51):20455–20460.  https://doi.org/10.1073/pnas.1114010108CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Bowers PM, Neben TY, Tomlinson GL, Dalton JL, Altobell L, Zhang X, Macomber JL, Wu BF, Toobian RM, McConnell AD, Verdino P, Chau B, Horlick RA, King DJ (2013) Humanization of antibodies using heavy chain complementarity-determining region 3 grafting coupled with in vitro somatic hypermutation. J Biol Chem 288(11):7688–7696.  https://doi.org/10.1074/jbc.M112.445502CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Ho M, Nagata S, Pastan I (2006) Isolation of anti-CD22 Fv with high affinity by Fv display on human cells. Proc Natl Acad Sci U S A 103(25):9637–9642.  https://doi.org/10.1073/pnas.0603653103CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Horlick RA, Macomber JL, Bowers PM, Neben TY, Tomlinson GL, Krapf IP, Dalton JL, Verdino P, King DJ (2013) Simultaneous surface display and secretion of proteins from mammalian cells facilitate efficient in vitro selection and maturation of antibodies. J Biol Chem 288(27):19861–19869.  https://doi.org/10.1074/jbc.M113.452482CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    King DJ, Bowers PM, Kehry MR, Horlick RA (2014) Mammalian cell display and somatic hypermutation in vitro for human antibody discovery. Curr Drug Discov Technol 11(1):56–64CrossRefGoogle Scholar
  13. 13.
    Li CZ, Liang ZK, Chen ZR, Lou HB, Zhou Y, Zhang ZH, Yu F, Liu S, Zhou Y, Wu S, Zheng W, Tan W, Jiang S, Zhou C (2012) Identification of HBsAg-specific antibodies from a mammalian cell displayed full-length human antibody library of healthy immunized donor. Cell Mol Immunol 9(2):184–190.  https://doi.org/10.1038/cmi.2011.55CrossRefPubMedGoogle Scholar
  14. 14.
    Mason DM, Weber CR, Parola C, Meng SM, Greiff V, Kelton WJ, Reddy ST (2018) High-throughput antibody engineering in mammalian cells by CRISPR/Cas9-mediated homology-directed mutagenesis. Nucleic Acids Res 46(14):7436–7449.  https://doi.org/10.1093/nar/gky550CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    McConnell AD, Do M, Neben TY, Spasojevic V, MacLaren J, Chen AP, Altobell L 3rd, Macomber JL, Berkebile AD, Horlick RA, Bowers PM, King DJ (2012) High affinity humanized antibodies without making hybridomas; immunization paired with mammalian cell display and in vitro somatic hypermutation. PLoS One 7(11):e49458.  https://doi.org/10.1371/journal.pone.0049458CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Schenk JA, Sellrie F, Bottger V, Menning A, Stocklein WF, Micheel B (2007) Generation and application of a fluorescein-specific single chain antibody. Biochimie 89(11):1304–1311.  https://doi.org/10.1016/j.biochi.2007.06.008CrossRefPubMedGoogle Scholar
  17. 17.
    Walsh G (2014) Biopharmaceutical benchmarks 2014. Nat Biotechnol 32(10):992–1000.  https://doi.org/10.1038/nbt.3040CrossRefPubMedGoogle Scholar
  18. 18.
    Nguyen AW, Le KC, Maynard JA (2018) Identification of high affinity HER2 binding antibodies using CHO Fab surface display. Protein Eng Des Sel 31(3):91–101.  https://doi.org/10.1093/protein/gzy004CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Kunaparaju R, Liao M, Sunstrom NA (2005) Epi-CHO, an episomal expression system for recombinant protein production in CHO cells. Biotechnol Bioeng 91(6):670–677.  https://doi.org/10.1002/bit.20534CrossRefPubMedGoogle Scholar
  20. 20.
    Bostrom J, Yu SF, Kan D, Appleton BA, Lee CV, Billeci K, Man W, Peale F, Ross S, Wiesmann C, Fuh G (2009) Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site. Science 323(5921):1610–1614.  https://doi.org/10.1126/science.1165480CrossRefPubMedGoogle Scholar
  21. 21.
    Colby DW, Kellogg BA, Graff CP, Yeung YA, Swers JS, Wittrup KD (2004) Engineering antibody affinity by yeast surface display. Methods Enzymol 388:348–358.  https://doi.org/10.1016/S0076-6879(04)88027-3CrossRefPubMedGoogle Scholar
  22. 22.
  23. 23.
    Bessette PH, Mena MA, Nguyen AW, Daugherty PS (2003) Construction of designed protein libraries using gene assembly mutagenesis. Methods Mol Biol 231:29–37.  https://doi.org/10.1385/1-59259-395-X:29CrossRefPubMedGoogle Scholar
  24. 24.
    Stemmer WP, Crameri A, Ha KD, Brennan TM, Heyneker HL (1995) Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides. Gene 164(1):49–53CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2020

Authors and Affiliations

  • Annalee W. Nguyen
    • 1
    Email author
  • Kevin Le
    • 1
  • Jennifer A. Maynard
    • 1
  1. 1.Department of Chemical EngineeringThe University of Texas at AustinAustinUSA

Personalised recommendations